Results 131 to 140 of about 135,991 (315)
Health Care Opinion Leaders' Views on Medicare Reform [PDF]
, 2009 Presents findings of a survey of experts on Medicare's successes and proposed reforms, including putting payment pilots on a fast track, negotiating drug prices, and creating an advisory council with authority to make payment and benefit design ...
Karen Davis +2 more
core
British Journal of Clinical Pharmacology, EarlyView.Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber +7 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.This original research used medication administration data to explore adherence to treatment guidelines for the most common osteoporosis medications in long‐term residential aged care (RAC) in Australia. The paper highlights gaps in adherence to treatment guidelines that must be addressed to improve outcomes of older adults living in RAC.
Marea O'Donnell +7 more
wiley +1 more source
The design of licensing contracts: Chemicals, Pharmaceuticals, and Electrical Engineering in Imperial Germany [PDF]
We investigate a sample of 180 technology licensing contracts closed by German chemical, pharmaceutical, and electrical engineering companies between 1880 and 1913.
Carsten Burhop, Thorsten Lübbers
core
Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices, Vol. 1 [PDF]
, 2007 Prepared by and for policy-makers, leaders of public sector research establishments, technology transfer professionals, licensing executives, and scientists, this online resource offers up-to-date information and strategies for utilizing the power of ...
Bennett, Alan B. +8 more
core +3 more sources
British Journal of Clinical Pharmacology, EarlyView.Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen +8 more
wiley +1 more source
Bulletin of the World Health Organization, 2003 OBJECTIVE: Household willingness to pay for treatment provides important information for programme planning. We tested for relationships between socioeconomic status, risk of trachoma, perceptions of the effects of azithromycin, and the household ...
Frick Kevin D. +4 more
doaj
, 2016 What are the costs and benefits of patent laws? While Congress and the courts are often able to evade this difficult question, there is one institutional actor that is not only well-advised but also required to consider costs and benefits: the Patent and
Masur, Jonathan S.
core +3 more sources
Evidence-Based Decision-Making Within Australia's Pharmaceutical Benefits Scheme [PDF]
, 2009 Provides an overview of Australia's Pharmaceutical Benefits Scheme and its consideration of both comparative effectiveness and cost-effectiveness in deciding on drug subsidies.
Ruth Lopert
core
Platform Business Model Innovation for Sustainability: A Framework for Industry 5.0 Integration
Business Strategy and the Environment, EarlyView.ABSTRACT A comprehensive framework is developed for adopting Platform Business Model Innovation (PBMI) to enhance sustainable performance in the Industry 5.0 (I5.0) era. While PBMI plays a growing role in corporate transformation, tensions persist between profit‐driven objectives and broader sustainability imperatives.
Mohamed Ashmel Mohamed Hashim +3 more
wiley +1 more source